News

Researchers around the world have been working diligently over the last 25 years to develop artificial corneas for patients who are not good candidates for the current techniques of keratoplasty, according to Eduardo C. Alfonso, MD.

San Diego-The Implantable Collamer Lens (ICL, STAAR Surgical) appears to be safe and effective for treating low to high myopia based on the 3-year FDA study results. There is, however, a low risk of developing a cataract as a result of implantation, explained Harry Grabow, MD, who reported the findings at the annual meeting of the American Society of Cataract and Refractive Surgery.The criteria for inclusion in the myopic ICL study were –3 to –20 D of spherical equivalent (mean preoperative refraction, –10 D) and up to 2.5 D of cylinder. The refractive results were good with a mean stable postoperative refraction of about –0.5 D.

Advanced Medical Optics (AMO, Santa Ana, CA) redefined its position in the ophthalmic community when it reached a definitive agreement April 21 to acquire Pfizer’s surgical ophthalmology business for $450 million in cash. The deal will boost AMO’s revenue base by 25% and allow the company bragging rights to the Healon line of viscoelastic products, the CeeOn and Tecnis IOLs, and the Baerveldt glaucoma shunt.“You don’t see many of these deals come across in a lifetime-in any industry,” said AMO President and Chief Executive Officer James V. Mazzo

More than 330 ophthalmologists from 24 states and several countriesattended "Glaucoma 2004: Mastering Tools and Techniques for the 21stCentury," on Friday, June 4, and Saturday, June 5, at the Plaza Hotel.

The use of antiproliferative agents has helped increase thelikelihood of successful filtering surgery by inhibiting the wound healingresponse. The problem is that these agents also contribute to the risk ofbleb leak and bleb-associated infection, reported Paul J. Lama, MD, of theUniversity of Medicine and Dentistry of New Jersey, Newark, and the Veterans'Administration Medical Center, East Orange, NJ.

What are the best approaches to the glaucoma suspect, establishedglaucoma patient, and the patient with low-tension glaucoma? Those weresome of the topics covered in the afternoon session on Friday, June 4.

Global risk assessment is a relatively new concept in ophthalmology.In the field of cardiology, risk factors to aid in treatment decisions havebeen used for 50 years. Cardiologists and internists document such factorsas blood pressure and serum lipid profiles in all patients to determinethose who are at risk and need treatment.

Automated perimetry is an important tool for the diagnosis andmanagement of glaucoma. Using this tool, clinicians can identify the abnormalvisual field and then monitor for ongoing visual field deterioration, saidJody R. Piltz-Seymour, MD, of the University of Pennsylvania, and the ScheieEye Institute, Philadelphia. She described the strengths and weaknessesof three systems currently used by clinicians.

Clinicians need to recognize the fundamental characteristicsof the glaucomatous optic nerve in daily practice. While understanding cup-to-discratio is important, it is also important to recognize other structural characteristics.